Please assess the completion status of the following clinical trial:

Trial Title: Investigating the Cryopreserved Blastocyst's ImplantatiOn Potential After Genetic Screening

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* at least 2 blastocysts suitable for biopsy on day 5 of embryo development remaining after fresh transfer~* willing and able to give informed consent~* infertility as an indication for IVF/ICSI~* first or second IVF/ICSI cycle~* patients willing to accept single embryo transfer~* BMI range 18 to 35 kg/m2~Exclusion Criteria:~* any type of genetic abnormality or family history of genetic abnormality in subject or partner~* any other non-study related preimplantation genetic testing~* three or more clinical miscarriages (recurrent pregnancy loss, RPL)~* recurrent implantation failure (RIF): no positive β-hCG after transfer (fresh IVF/ICSI cycle or frozen) with no less than 6 cleavage stage embryos or no less than 4 blastocysts, all of good quality and of appropriate developmental stage~* severe endometriosis~* abnormal uterine cavity~* cycles requiring surgical sperm recovery procedures, total asthenozoospermia and/or globozoospermia~* treatment involving use of donor oocytes or use of gestational carrier

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 37 Years
- Healthy Volunteers: f

Study Arms:
- PGS (genetic screening) (Type: EXPERIMENTAL): Intent to transfer single cryopreserved embryo, selection based on euploid status (after preimplantation genetic screening) and standard morphological assessment
- no PGS (no genetic screening) (Type: NO_INTERVENTION): Intent to transfer single cryopreserved embryo, selection based on standard morphological assessment

Based on this trial design, predict the completion outcome and termination type (if applicable).